O
The startup develops drug therapies utilizing nitrogen monoxide to treat brain diseases, autoimmune disorders, and cancer by facilitating its delivery across the blood-brain barrier. Their research demonstrates effective chemical modification techniques that enhance treatment outcomes for conditions like rheumatoid arthritis.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops drug therapies utilizing nitrogen monoxide to treat brain diseases, autoimmune disorders, and cancer by facilitating its delivery across the blood-brain barrier. Their research demonstrates effective chemical modification techniques that enhance treatment outcomes for conditions like rheumatoid arthritis.